Business & funding Story
Oura acquires AI primary care startup Counsel Health for $625 million as its IPO stays on hold
Oura announced on 10 November 2026 that it will acquire AI-native primary care company Counsel Health for $625 million in cash, while its IPO of up to $2.2 billion remains postponed indefinitely.
This story was written with the help of artificial intelligence, checked automatically, then reviewed by an editor before publication, under our AI policy.
The deal and its terms
Oura has announced the acquisition of Counsel Health, a primary care company built around artificial intelligence, for $625 million, TechCrunch reported on 10 November 2026. According to Oura's announcement, the purchase is paid in cash and is subject to price adjustments.
The sources disagree on timing. Oura's release provides for closing before the end of the calendar year, under usual conditions. TechCrunch writes: “The deal is expected to close before the end of 2027.” The discrepancy is not explained in the material available.
An IPO on hold
What Counsel Health brings
Counsel combines a chat-style medical AI with in-house physicians, and the service has been built into the Oura app since June, according to TechCrunch. Per the announcement, a user can talk to Counsel's AI and, when needed, move to a board-certified doctor within minutes without leaving the Oura app.
Oura says that among members using Counsel, more than 90% report that their Oura data helped them take better care of their health. This figure is a company claim, and the announcement as summarised does not describe how it was measured.
Counsel's CEO, Muthu Alagappan, joins Oura as chief clinical AI officer, together with the company's 70 employees, according to Bloomberg as cited by TechCrunch.
Funding history and growth claims
Counsel raised a $25 million Series A a year ago, led by Andreessen Horowitz (a16z) and GV, TechCrunch reports. PitchBook estimates its total funding at $36 million. The $625 million price is therefore well above the capital the startup is estimated to have raised.
On its own numbers, Oura says revenue for the quarter ended 30 September 2026 grew 153% year on year to $533 million, with adjusted EBITDA of $87 million (a 16% margin). Oura describes these results as preliminary and unaudited. For fiscal 2026, the company says it expects revenue of about $1.75 billion, up 92% year on year. Executive chairman David Shuman refers to “our over six million members”, a figure stated by the company.
Plans after the acquisition
Oura says Counsel will keep serving its existing and new enterprise partners, with the aim of extending its model to millions of patients beyond Oura members. The two companies also plan to widen their partnership to prevention, acute care, and specialty and chronic care.
The announcement as summarised does not give timelines or regulatory details for these expansions, nor does it explain the gap in closing dates.
| Metric | Figure | Period |
|---|---|---|
| Revenue | $533 million (+153% year on year) | Quarter ended 30 September 2026 |
| Adjusted EBITDA | $87 million (16% margin) | Quarter ended 30 September 2026 |
| Revenue | About $1.75 billion (+92% year on year) | Fiscal 2026 |
FAQ
How much is Oura paying for Counsel Health?
Oura is paying $625 million in cash, subject to price adjustments, according to its announcement.
When will the acquisition close?
Oura's release says before the end of the calendar year; TechCrunch says before the end of 2027.
What happens to Counsel's existing clients?
Oura says Counsel will continue to serve its existing and new enterprise partners.